79 related articles for article (PubMed ID: 1724838)
21. [Histological and cytofluorometric investigations of immunodeficient CB17 scid/scid mice].
Ladel CH; Bamberger U; Püschner H
Verh Dtsch Ges Pathol; 1991; 75():108-13. PubMed ID: 1724810
[TBL] [Abstract][Full Text] [Related]
22. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
23. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
IARC Sci Publ; 1985; (60):249-64. PubMed ID: 2998992
[TBL] [Abstract][Full Text] [Related]
24. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
25. c-MYC impairs immunogenicity of human B cells.
Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW
Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945
[TBL] [Abstract][Full Text] [Related]
26. PNAEmu can significantly reduce Burkitt's lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease.
Matis S; Mariani MR; Cutrona G; Cilli M; Piccardi F; Daga A; Damonte G; Millo E; Moroni M; Roncella S; Fedeli F; Boffa LC; Ferrarini M
Cancer Gene Ther; 2009 Oct; 16(10):786-93. PubMed ID: 19363465
[TBL] [Abstract][Full Text] [Related]
27. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemia.
de Kroon JF; Kluin-Nelemans HC; Kluin PM; Schuuring E; van Bergen CA; Oving I; Wessels H; Willemze R; Falkenburg JH
Exp Hematol; 1997 Sep; 25(10):1062-8. PubMed ID: 9293903
[TBL] [Abstract][Full Text] [Related]
29. Forward and reverse changes in Ig/myc translocation carrying tumors.
Klein G
Princess Takamatsu Symp; 1989; 20():135-42. PubMed ID: 2562178
[TBL] [Abstract][Full Text] [Related]
30. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
Freund GG; Kulas DT; Way BA; Mooney RA
Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
[TBL] [Abstract][Full Text] [Related]
31. Long-term chimera produced by transplantation of human fetal liver cells into severe combined immunodeficiency mice.
Sanhadji K; Chargui J; Touraine JL
Transplant Proc; 1993 Feb; 25(1 Pt 1):452. PubMed ID: 8438375
[No Abstract] [Full Text] [Related]
32. Characterization of human pancreatic adenocarcinoma cell line with high metastatic potential in SCID mice.
Siedlar M; Stachura J; Szczepanik A; Popiela T; Mattei M; Vendetti S; Colizzi V; Zembala M
Invasion Metastasis; 1995; 15(1-2):60-9. PubMed ID: 7545654
[TBL] [Abstract][Full Text] [Related]
33. Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines, GAL-01 and GAL-02, from a primary lymphomatous effusion.
Thielen C; Herens C; Fassotte MF; Detrooz E; Drion P; Diss T; Boniver J; de Leval L
Eur J Haematol; 2006 Oct; 77(4):318-26. PubMed ID: 16856916
[TBL] [Abstract][Full Text] [Related]
34. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.
Golay J; Erba E; Bernasconi S; Peri G; Introna M
J Immunol; 1994 Jul; 153(2):543-53. PubMed ID: 8021494
[TBL] [Abstract][Full Text] [Related]
35. Enhanced tumorigenicity of an Epstein-Barr virus-transformed lymphoblastoid cell line is associated with a unique 1:18 chromosomal translocation and decreased expression of lymphocyte function associated antigen-1a (CD11A).
Picchio GR; Cohen JI; Wyatt ER; Mosier DE
Am J Pathol; 1993 Aug; 143(2):342-9. PubMed ID: 8393615
[TBL] [Abstract][Full Text] [Related]
36. Establishment and characterization of new human Burkitt's lymphoma cell lines (HBL-7 and HBL-8) that are highly metastatic in SCID mice: a metastatic SCID mouse model of human lymphoma lines.
Abe M; Suzuki O; Tasaki K; Abe R; Wakasa H
Pathol Int; 1996 Sep; 46(9):630-8. PubMed ID: 8905871
[TBL] [Abstract][Full Text] [Related]
37. A phenotypic study of cells from Burkitt lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissues.
Ling NR; Hardie D; Lowe J; Johnson GD; Khan M; MacLennan IC
Int J Cancer; 1989 Jan; 43(1):112-8. PubMed ID: 2536003
[TBL] [Abstract][Full Text] [Related]
38. Diploid human lymphoblastoid and Burkitt lymphoma cell lines: susceptibility to murine NK cells and heterotransplantation to nude mice.
McCormick KH; Giovanella BC; Klein G; Nilsson K; Stehlin JS
Int J Cancer; 1981 Oct; 28(4):455-8. PubMed ID: 6273332
[TBL] [Abstract][Full Text] [Related]
39. [Pathogenesis and histomorphology of the so-called Omenn syndrome].
Vossbeck S; Friedrich W; Heymer B
Verh Dtsch Ges Pathol; 1991; 75():121-5. PubMed ID: 1724813
[TBL] [Abstract][Full Text] [Related]
40. Expression of type IV collagenase correlates with the invasion of human lymphoblastoid cell lines and pathogenesis in SCID mice.
Hendrix MJ; Seftor EA; Grogan TM; Seftor RE; Hersh EM; Boyse EA; Liotta LA; Stetler-Stevenson W; Ray CG
Mol Cell Probes; 1992 Feb; 6(1):59-65. PubMed ID: 1312223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
